Ethoxycarbonyl Group

Ethoxycarbonyl Group

SCHEMBL4428871

CCCC.CCOC=O.NC(O)=S.NC(O)=S

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethoxycarbonyl Group SCHEMBL11691061 0.95 ALOX15 (0.35) ALOX15
Ethoxycarbonyl Group SCHEMBL4879176 0.93 ALOX15 (0.33) ALOX15
Ethoxycarbonyl Group SCHEMBL4877557 0.93 ALOX15 (0.33) ALOX15
Hexane SCHEMBL4881617 0.91 MEN1 (0.34) ALOX15
Benzene SCHEMBL4437867 0.91 ALOX15 (0.32) ALOX15
Octane SCHEMBL7865572 0.90 MEN1 (0.37) ALOX15
Ethoxycarbonyl Group SCHEMBL11692943 0.85 ALOX15 (0.38) ALOX15
Propylformate SCHEMBL27764690 0.84 HCAR2 (0.32)
Ethoxycarbonyl Group SCHEMBL27767802 0.83
Propylformate SCHEMBL27856733 0.82 HCAR2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8376142-B2 Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies CYTEC TECHNOLOGY CORP. (US) 2013-02-19 US claimed
EP-2117718-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. (US) 2009-11-18 EP claimed
WO-2008097707-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. (US) 2008-08-14 WO claimed
US-20080185317-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. 2008-08-07 US claimed
EP-2117718-B1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES CYTEC TECH CORP (US) 2017-05-10 EP disclosed
CN-103433145-B Use the method for the beneficiation of mineral ore bodies of dithiocarbamate collector CYTEC TECH CORP (US) 2015-08-12 CN disclosed
CN-101605608-B Dithiocarbamate collectors and their use in mineral processing CYTEC TECH CORP 2014-03-12 CN disclosed
CN-103433145-A Novel dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies CYTEC TECH CORP 2013-12-11 CN disclosed
US-8376142-B2 Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies CYTEC TECHNOLOGY CORP. (US) 2013-02-19 US disclosed
CN-101605608-A Novel dithiocarbamate collector and application thereof in mineral separation CYTEC TECH CORP (US) 2009-12-16 CN disclosed
EP-2117718-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. (US) 2009-11-18 EP disclosed
WO-2008097707-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. (US) 2008-08-14 WO disclosed
US-20080185317-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080185317-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES FTH1, FECH, SLC40A1 ALOX15 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.